Table 1 Clinical and epidemiological data obtained for the 36 patients of collective A and B
From: Hospital outbreak caused by linezolid resistant Enterococcus faecium in Upper Austria
| Characteristics | ||
|---|---|---|
| Age, years, median (range) | 57 (22–91) | |
| Sex, n (%) | ||
| Male | 23 | 63.9 |
| Female | 13 | 36.1 |
| Patient status, n (%) | ||
| Inpatient | 35 | 97.2 |
| Outpatient | 1 | 2.8 |
| Transfer from other Hospital/LTCF, n (%) | ||
| Yes | 8 | 22.2 |
| No | 25 | 69.4 |
| Unknown | 3 | 8.3 |
| LZD therapy (previous 28 days), n (%) | ||
| Yes | 10 | 27.8 |
| No | 25 | 69.4 |
| Unknown | 1 | 2.8 |
| Duration of LZD therapy, days, median (range) | 9 (3–35) | |
| LREfm status, n (%) | ||
| Infection | 4 | 11.1 |
| Colonization | 30 | 83.3 |
| Unknown | 2 | 5.6 |
| Duration of colonization, days, median (range) | 22 (3–245) | |
| Current antibiotic therapy, n (%) | ||
| Yes | 36 | 100.0 |
| No | 0 | 0.0 |
| Hospital contact in previous year, n (%) | ||
| Yes | 31 | 86.1 |
| No | 2 | 5.6 |
| Unknown | 3 | 8.3 |
| Underlying disease, n (%) | ||
| Hematology-Oncology | 25 | 69.4 |
| allogeneic SCT | 17 | |
| autologous SCT | 3 | |
| Trauma/orthopedic | 4 | 11.1 |
| Abdominal surgery/Pancreatitis | 4 | 11.1 |
| Other | 3 | 8.3 |
| Immunocompromised, n (%) | ||
| Yes | 31 | 86.1 |
| No | 4 | 11.1 |
| Unknown | 1 | 2.8 |
| Died during follow-up (until end of 2017), n (%) | ||
| Yes | 15 | 41.7 |
| No | 14 | 38.9 |
| Unknown | 7 | 19.4 |
| Source material first LREfm isolate, n (%) | ||
| Stool | 18 | 50.0 |
| Urine | 9 | 25.0 |
| Swab (wound, throat, eye) | 7 | 19.4 |
| Blood culture | 1 | 2.8 |
| Catheter tip | 1 | 2.8 |
| Source material secondary isolates, n (%) | ||
| Stool | 6 | |
| Blood culture | 2 | |
| Urine | 1 | |
| Screening sample, n (%) | ||
| Yes | 24 | 66.6 |
| No | 11 | 30.5 |
| Unknown | 1 | 2.77 |
